Schlossberg minced no words about the damage she believes Kennedy’s actions have and will inflict on cancer patients and on medical research.
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...
Doctors say her struggle - even with the best care as a member of a prominent family - emphasises the need for more research.
Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the ...
Clinical validation successfully completed with Mayo Clinic Platform’s Validate program - marking the final clinical requirement prior to FDA 510(k) submission EchoSolv HF validation met the primary ...